Then survival analysis and cox regression were performed based on the mRNA level of MAP-17 (PDZK1IP1) in TCGA-PAAD cohort to examine whether MAP-17 (PDZK1IP1) had consistent survival relevance with SGLT-1 (SLC5A1). The gene discussed is SLC5A1; the disease is pancreatic adenocarcinoma.